Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dynavax releases Phase 1b hepatitis B vaccine trial results
Dynavax said that the candidate vaccine, DV-601, is designed to induce an immune response against HBV-infected cells and if proven to be safe and effective, may offer an
Dynavax said that the candidate vaccine, DV-601, is designed to induce an immune response against HBV-infected cells and if proven to be safe and effective, may offer an
In its CRL the FDA said that it will not approve the application as it is. The FDA further said that the 0.5ml formulation contained the same active
The NDA seeks approval to market Iluvien (fluocinolone acetonide intravitreal insert), an investigational, sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for the treatment of
Dell said the combination of InSite One’s cloud-based, vendor-neutral archive software and storage services with Dell’s Unified Clinical Archive solution will simplify data retention and let medical professionals
Under the terms of a license agreement for ATL313 entered into by the two companies, the IND filing will trigger a $2m milestone payment to Clinical Data on
The preclinical collaboration is being conducted with Marina Konopleva, associate professor in the Department of Leukemia at MD Anderson Cancer Center. The research collaboration will focus on characterizing
As per the terms of the licensing agreement, Bracco has been granted exclusive rights in Italy to commercialize and market Vitaros under the Bracco trademark. The tie up
RockHard is recalling Weekend Lot Numbers: 100159 and 100260 sold as blister packs, 3ct bottles and 8ct bottles, in addition Pandora Lot Numbers: 100378 sold as blister packs
Prevnar 13, which is based on the scientific foundation of Prevnar, was approved for use in infants and young children in Europe in December 2009 and in the
Amturnide is approved for patients whose blood pressure is not adequately controlled with any two of its individual components and is not indicated as initial therapy for high